Results 41 to 50 of about 33,318 (283)

Oral Protein Therapy for the Future - Transport of Glycolipid-Modified Proteins: Vision or Fiction? [PDF]

open access: yes, 2010
The reliable and early diagnosis of common complex multifactorial diseases depends on the individual determination of all (or as many as possible) polymorphisms of each susceptibility gene together with amount and type of the corresponding gene products ...
Mueller, Guenter
core   +1 more source

Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study [PDF]

open access: yes, 2015
Objectives The interleukin-6 receptor (IL-6R) blocker tocilizumab (TCZ) reduces inflammatory disease activity in rheumatoid arthritis (RA) but elevates lipid concentrations in some patients.
Bathon, Joan M.   +10 more
core   +1 more source

Chylomicrons promote intestinal absorption of lipopolysaccharides Published, JLR Papers in Press, September 24, 2008.

open access: yesJournal of Lipid Research, 2009
Recent data suggest that dietary fat promotes intestinal absorption of lipopolysaccharides (LPS) from the gut microflora, which might contribute to various inflammatory disorders.
S. Ghoshal   +4 more
semanticscholar   +1 more source

Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36 [PDF]

open access: yes, 2016
Cluster of differentiation 36 (CD36) variants influence fasting lipids and risk of metabolic syndrome, but their impact on postprandial lipids, an independent risk factor for cardiovascular disease, is unclear. We determined the effects of SNPs within a ~
Abumrad, Nada A   +13 more
core   +2 more sources

Ultrastructural Demonstration of the Absorption and Transportation of Minute Chylomicrons by Subepithelial Blood Capillaries in Rat Jejunal Villi

open access: yesJournal of Veterinary Medical Science, 2013
Chylomicrons from villous columnar epithelial cells are generally known to be transported only by central lymph vessels (CLV), whereas antigenic particulates derived from the intestinal lumen can also be transported by subepithelial blood capillaries ...
E. Takahara   +8 more
semanticscholar   +1 more source

Postprandial apoE isoform and conformational changes associated with VLDL lipolysis products modulate monocyte inflammation. [PDF]

open access: yes, 2012
ObjectivePostprandial hyperlipemia, characterized by increased circulating very low-density lipoproteins (VLDL) and circulating lipopolysaccharide (LPS), has been proposed as a mechanism of vascular injury.
Altman, Robin   +10 more
core   +3 more sources

The GTPase ARFRP1 controls the lipidation of chylomicrons in the Golgi of the intestinal epithelium

open access: yesHuman Molecular Genetics, 2012
The uptake and processing of dietary lipids by the small intestine is a multistep process that involves several steps including vesicular and protein transport.
A. Jaschke   +12 more
semanticscholar   +1 more source

Triglyceride-rich lipoproteins prevent septic death in rats. [PDF]

open access: yes, 1995
Triglyceride-rich lipoproteins bind and inactive bacterial endotoxin in vitro and prevent death when given before a lethal dose of endotoxin in animals.
Calhoun, MC   +6 more
core  

Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1991
Chylomicron catabolism is known to be initiated by the enzyme lipoprotein lipase (triacylglycero-protein acylhydrolase, EC 3.1.1.34). Chylomicron remnants, produced by lipolysis, are rapidly taken up by the liver via an apolipoprotein E (apoE)-mediated ...
U. Beisiegel   +2 more
semanticscholar   +1 more source

Surface Engineering of Thrombus‐Targeting Nanocarriers for Cardiovascular Diseases: A Short Review

open access: yesAdvanced Materials Interfaces, EarlyView.
This paper systematically introduces surface modification strategies for thrombus‐targeting nanocarriers, highlights the clinical significance of nanocarrier‐based thrombolysis therapies, and prospects the synergy of combing thrombolysis and anti‐inflammatory therapies for enhanced therapeutic effect.
Xinyue Ge   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy